Lisanti Capital Growth LLC Acquires 92,600 Shares of Schrodinger, Inc. $SDGR

Lisanti Capital Growth LLC bought a new stake in shares of Schrodinger, Inc. (NASDAQ:SDGR) in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 92,600 shares of the company’s stock, valued at approximately $2,875,000. Lisanti Capital Growth LLC owned approximately 0.13% of Schrodinger as of its most recent SEC filing.

Several other hedge funds have also made changes to their positions in the company. BlackRock Inc. purchased a new position in shares of Schrodinger during the second quarter valued at $170,978,000. Rubric Capital Management LP raised its holdings in shares of Schrodinger by 43.8% in the first quarter. Rubric Capital Management LP now owns 6,000,000 shares of the company’s stock valued at $68,160,000 after acquiring an additional 1,828,502 shares in the last quarter. Amova Asset Management Americas Inc. raised its holdings in shares of Schrodinger by 13.2% in the first quarter. Amova Asset Management Americas Inc. now owns 3,190,837 shares of the company’s stock valued at $36,248,000 after acquiring an additional 371,167 shares in the last quarter. Bank of New York Mellon Corp purchased a new stake in Schrodinger in the second quarter worth about $4,986,000. Finally, Tejara Capital Ltd purchased a new stake in Schrodinger in the second quarter worth about $4,553,000. 79.05% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at Schrodinger

In other news, EVP Yvonne Tran sold 32,000 shares of the firm’s stock in a transaction dated Monday, November 9th. The shares were sold at an average price of $32.85, for a total value of $1,051,200.00. Following the sale, the executive vice president directly owned 52,683 shares in the company, valued at approximately $1,730,636.55. This trade represents a 37.79% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Karen Akinsanya sold 31,599 shares of the stock in a transaction that occurred on Thursday, September 17th. The shares were sold at an average price of $29.37, for a total transaction of $928,062.63. Following the sale, the insider directly owned 69,956 shares of the company’s stock, valued at $2,054,607.72. The trade was a 31.12% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 10.10% of the stock is currently owned by company insiders.

Schrodinger Trading Down 2.7%

Shares of NASDAQ:SDGR opened at $31.52 on Thursday. Schrodinger, Inc. has a 12-month low of $10.94 and a 12-month high of $34.00. The business’s fifty day simple moving average is $26.55 and its 200-day simple moving average is $17.32. The company has a market capitalization of $2.33 billion, a PE ratio of -39.90 and a beta of 1.69.

Schrodinger (NASDAQ:SDGR) last released its quarterly earnings results on Wednesday, November 4th. The company reported ($0.50) EPS for the quarter, topping the consensus estimate of ($0.67) by $0.17. The firm had revenue of $64.49 million during the quarter, compared to analyst estimates of $47.73 million. Schrodinger had a negative return on equity of 18.12% and a negative net margin of 22.02%. The business’s revenue for the quarter was up 18.7% compared to the same quarter last year. During the same period in the previous year, the company posted ($0.45) EPS. Research analysts predict that Schrodinger, Inc. will post -1.39 EPS for the current year.

Analysts Set New Price Targets

SDGR has been the topic of several recent research reports. UBS Group increased their target price on shares of Schrodinger from $19.00 to $21.00 and gave the stock a “neutral” rating in a report on Tuesday, October 20th. Wall Street Zen upgraded shares of Schrodinger from a “strong sell” rating to a “hold” rating in a report on Saturday, August 8th. BMO Capital Markets upped their price target on shares of Schrodinger from $24.00 to $30.00 and gave the stock an “outperform” rating in a research report on Monday, October 12th. Zacks Research downgraded shares of Schrodinger from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, November 3rd. Finally, Weiss Ratings upgraded shares of Schrodinger from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Thursday, August 27th. Four analysts have rated the stock with a Buy rating, three have given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, Schrodinger has an average rating of “Hold” and a consensus target price of $26.67.

About Schrodinger

Schrödinger, Inc. develops computational software used to support drug discovery and materials research. Its platform applies physics-based modeling, computational chemistry and machine learning to help researchers analyze molecular properties and identify promising candidates. The company’s tools are used by pharmaceutical and biotechnology companies, academic institutions and other research organizations. Alongside software sales and subscriptions, Schrödinger works with partners on drug discovery programs and advances a portfolio of its own therapeutic candidates.